Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Tetrahedron|November 20, 2013
Synthetic studies on the icetexones: enantioselective formal syntheses of icetexone and epi-icetexoneFelipe de Jesus Cortez, David Lapointe, Amy M Hamlin, et al.The American Journal of Pathology|May 3, 2006
Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosoureaTaichang Jang, Todd Savarese, Hoi Pang Low, et al.Journal of Cellular Biochemistry|April 22, 2003
Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP-2-mediated osteoblast differentiationEva Balint, David Lapointe, Hicham Drissi, et al.Journal of Virology|October 15, 2003
Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cellsRajas V Warke, Kris Xhaja, Katherine J Martin, et al.Plos Genetics|January 4, 2013
A synthetic interaction screen identifies factors selectively required for proliferation and TERT transcription in p53-deficient human cancer cellsLi Xie, Claude Gazin, Sung Mi Park, et al.The Journal of Biological Chemistry|July 16, 2008
Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitorsNadiya M Teplyuk, Mario Galindo, Viktor I Teplyuk, et al.The Journal of Biological Chemistry|December 14, 2011
Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motilityMargaretha van der Deen, Jacqueline Akech, David Lapointe, et al.Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2Daniel W Young, Mohammad Q Hassan, Xiao-Qing Yang, et al.Journal of Medicinal Chemistry|December 4, 2024
Discovery of ART0380, a Potent and Selective ATR Kinase Inhibitor Undergoing Phase 2 Clinical Studies for the Treatment of Advanced or Metastatic Solid CancersChristopher L Carroll, Michael G Johnson, Yanbing Ding, et al.Pageof 2